Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupThoracic TumorsDiseaseLung Carcinoma, Small CellMerkel Cell CarcinomaSubgroupICD10C34.-C44.9MeSHCarcinoma, Merkel CellSmall Cell Lung CarcinomaSequenceChemotherapyChemo-substanceCisplatinEtoposideChemo-substanceCisplatinEtoposideChemo-substanceCisplatinEtoposideChemo-substanceCisplatinEtoposideNo. Substances2 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideNo. Substances8Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentionpalliativeRisksEmetogenicity (MASCC/ESMO)Febrile NeutropeniaNeutropenia only studiesPublicationAuthorSundstrøm SDiseaseKleinzelliges LungenkarzinomOriginDepartment of Oncology, University Hospital of TrondheimProtocols in Revision 1 protocol foundProtocols under revision.Cisplatin 75 / Etoposide (100/200), Small Cell Lung Cancer (PID2558 V1.0)
